3-iodobenzylguanidine has been researched along with Colorectal Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barthel, B; Beck, NI; Höpfner, M; Jockers-Scherübl, MC; Maaser, K; Scherübl, H; Sutter, AP; Zeitz, M | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Colorectal Cancer
| Article | Year |
|---|---|
Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Division; Colorectal Neoplasms; DNA Primers; Dose-Response Relationship, Drug; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Intracellular Membranes; L-Lactate Dehydrogenase; Membrane Potentials; Mitochondria; Neoplasm Proteins; Neuroendocrine Tumors; Norepinephrine Plasma Membrane Transport Proteins; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Symporters; Tumor Cells, Cultured | 2002 |